0001209191-17-017880.txt : 20170303
0001209191-17-017880.hdr.sgml : 20170303
20170303174927
ACCESSION NUMBER: 0001209191-17-017880
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170301
FILED AS OF DATE: 20170303
DATE AS OF CHANGE: 20170303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TENET HEALTHCARE CORP
CENTRAL INDEX KEY: 0000070318
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
IRS NUMBER: 952557091
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
BUSINESS PHONE: 469-893-2200
MAIL ADDRESS:
STREET 1: 1445 ROSS AVENUE
STREET 2: SUITE 1400
CITY: DALLAS
STATE: TX
ZIP: 75202
FORMER COMPANY:
FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cancelmi Daniel J
CENTRAL INDEX KEY: 0001396106
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07293
FILM NUMBER: 17665593
MAIL ADDRESS:
STREET 1: 13737 NOEL ROAD
STREET 2: SUITE 100
CITY: DALLAS
STATE: TX
ZIP: 75240
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-03-01
0
0000070318
TENET HEALTHCARE CORP
THC
0001396106
Cancelmi Daniel J
1445 ROSS AVENUE
SUITE 1400
DALLAS
TX
75202
0
1
0
0
Chief Financial Officer
2017 March Restricted Stock Units
2017-03-01
4
A
0
40373
0.00
A
Common Stock
40373
40373
D
2017 March Performance Stock Options (Right to Buy)
18.99
2017-03-01
4
A
0
89976
0.00
A
2027-03-01
Common Stock
89976
89976
D
These time-based restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant. Restricted stock units are settled in shares of the Company's common stock upon vesting.
These performance-based stock options vest on the third anniversary of the date of grant, subject to the satisfaction of a stock price performance condition requiring the Company's common stock price to close at or above $23.74 per share for any 20 consecutive trading days during the three-year period following the date of grant.
Anthony L. Shoemaker, as Attorney-in-Fact for Daniel J. Cancelmi
2017-03-03